CNVT yields 5000000.00% · JNJ yields 2.13%● Live data
📍 CNVT pulled ahead of the other in Year 1
Combined, CNVT + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CNVT + JNJ for your $10,000?
CVF Technologies Corporation engages in the investment, development, and management of early stage private companies that operate in the environmental technology sector in the United States and Canada. The company, through its interests in Xylodyne Corporation, develops proprietary technology relating to electric vehicles. CVF Technologies, through its subsidiary, Ecoval Corporation, involves in the development, manufacture, and marketing of organic herbicides, insecticides, and tree recovery systems primarily for the lawn and garden retail/consumer market, and specialty agricultural markets. The company, through its other subsidiary, G.P. Royalty Distribution Corporation, provides products and services to the jewelry industry to enable diamonds and other precious gems to be uniquely identified non-invasively using a patented low power laser imaging system. CVF Technologies was founded in 1989 and is based in Williamsville, New York.
Full CNVT Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.